Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'methamphetamine use'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Peroutka SJ Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine... N Engl J Med 1987
Peroutka SJ, Pascoe N, Fa... Monoamine metabolites in the cerebralspinal fluid of recreational user... Research Comm in Sub... 1987
O'Hearn E, Battaglia G, D... Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... J Neurosci 1988
Peroutka SJ, Newman H, Ha... Subjective effects of 3,4-methylenedioxymethamphetamine in recreationa... Neuropsychopharmacol... 1988
Price LH, Ricaurte GA, Kr... Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-m... Arch Gen Psychiatry 1989
Hashimoto K, Goromaru T Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-m... Neuropharmacology 1990
McCann UD, Ricaurte GA Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine... J Clin Psychopharmac... 1991
Kosten TR, Price LH Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use [C... Journal of Nervous &... 1992
Krystal JH, Price LH, Ops... Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood ... Am J Drug Alcohol Ab... 1992
Liester MB, Grob CS, Brav... Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use J Nerv Ment Dis 1992
Lim HK, Zeng S, Foltz RL Comparative investigation of disposition of 3,4-(methylenedioxy)metham... J Pharm Biomed Anal 1992
Hooft PJ, van de Voorde H... Reckless behaviour related to the use of 3,4-methylenedioxymethampheta... Int J Legal Med 1994
McGuire PK, Cope H, Fahy ... Diversity of psychopathology associated with use of 3,4-methylenedioxy... Br J Psychiatry 1994
Hanyu S, Ikeguchi K, Imai... Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ... Eur Neurol 1995
Cohen RS Adverse symptomatology and suicide associated with the use of methylen... Biol Psychiatry 1996
Crifasi J, Long C Traffic fatality related to the use of methylenedioxymethamphetamine J Forensic Sci 1996
Nakahara Y, Kikura R Hair analysis for drugs of abuse. XVIII. 3,4-Methylenedioxymethampheta... Biol Pharm Bull 1997
Cohen RS, Cocores J Neuropsychiatric manifestations following the use of 3,4-methylenediox... Prog Neuropsychophar... 1997
Kikura R, Nakahara Y, Mie... Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxyme... Forensic Sci Int 1997
Huether G, Zhou D, Ruther... Causes and consequences of the loss of serotonergic presynapses elicit... J Neural Transm 1997
Malberg JE, Seiden LS Small changes in ambient temperature cause large changes in 3,4-methyl... J Neurosci 1998
Redfearn PJ, Agrawal N, M... An association between the regular use of 3,4 methylenedioxy-methamphe... Addiction 1998
Nakahara Y, Kikura R, Tak... Hair analysis for drugs of abuse XX. Incorporation and behaviors of se... Life Sci 1998
Milosevic A, Agrawal N, R... The occurrence of toothwear in users of Ecstasy (3,4-methylenedioxymet... Community Dent Oral ... 1999
Chang L, Ernst T, Grob CS... Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymetha... J Magn Reson Imaging 1999
McCann UD, Mertl M, Eligu... Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA... Psychopharmacology (... 1999
Dafters RI, Duffy F, O'Do... Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in... Psychopharmacology (... 1999
McCann UD, Eligulashvili ... Altered neuroendocrine and behavioral responses to m-chlorophenylpiper... Psychopharmacology (... 1999
Erdtmann-Vourliotis M, Ma... Acute injection of drugs with low addictive potential (delta(9)-tetrah... Brain Res Mol Brain ... 1999
Jayanthi S, Ladenheim B, ... Overexpression of human copper/zinc superoxide dismutase in transgenic... Neuroscience 1999
Gorman EM, Carroll RT Substance abuse and HIV: considerations with regard to methamphetamine... J Assoc Nurses AIDS ... 2000
Nakahara Y, Hanajiri R Hair analysis for drugs of abuse XXI. Effect of para-substituents on b... Life Sci 2000
Rothman RB, Partilla JS, ... Neurochemical neutralization of methamphetamine with high-affinity non... Synapse 2000
Zenenberg R, Goldfarb DS Evaluation of hyponatremia associated with the use of methylenedioxyme... Int J Med Toxicol 2000
Bhattachary S, Powell JH Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecsta... Psychol Med 2001
Carvalho M, Carvalho F, B... Is hyperthermia the triggering factor for the hepatoxicity induced by ... Arch Toxicol 2001
MacInnes, N, Handley, SL ... Former chronic methylenedioxymethamphetamine (mdma or ecstasy) users r... J Psychopharmacology 2001
Navarro M, Pichini S, Far... Usefulness of saliva for measurement of 3,4- methylenedioxymethampheta... Clinical Chemistry 2001
Gerra G, Zaimovic A, Ampo... Experimentally induced aggressive behavior in subjects with 3,4- methy... Journal of Substance... 2001
Ho E, Karimi-Tabesh L, Ko... Characteristics of pregnant women who use Ecstasy (3, 4- methylenediox... Neurotoxicol Teratol 2001
Colado MI, Camarero J, Me... A study of the mechanisms involved in the neurotoxic action of 3,4- me... Br J Pharmacol 2001
Reneman L, Majoie CB, Fli... Reduced N-acetylaspartate levels in the frontal cortex of 3,4- methyle... AJNR Am J Neuroradio... 2002
Pichini S, Navarro M, Far... On-site testing of 3,4-methylenedioxymethamphetamine (ecstasy) in sali... Clin Chem 2002
Gesi M, Lenzi P, Soldani ... Morphological effects in the mouse myocardium after methylenedioxymeth... Anat Rec 2002
Camarero J, Sanchez V, O'... Studies, using in vivo microdialysis, on the effect of the dopamine up... J Neurochem 2002
Zakzanis KK, Young DA, Ra... Attentional processes in abstinent methylenedioxymethamphetamine (ecst... Appl Neuropsychol 2002
Brecht ML, von Mayrhauser... Differences between ecstasy-using and non-using methamphetamine users J Psychoactive Drugs 2002
Fantegrossi WE, Godlewski... Pharmacological characterization of the effects of 3,4-methylenedioxym... Psychopharmacology (... 2003
Zhou JF, Zhou YH, Zhang L... 3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acety... Biomed Environ Sci 2003
Zhou JF, Chen P, Zhou YH,... 3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative str... Free Radic Res 2003
Gerra G, Bassignana S, Za... Hypothalamic-pituitary-adrenal axis responses to stress in subjects wi... Psychiatry Res 2003
Back-Madruga C, Boone KB,... Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA ... Clin Neuropsychol 2003
London ED, Simon SL, Berm... Mood disturbances and regional cerebral metabolic abnormalities in rec... Arch Gen Psychiatry 2004
Wang GJ, Volkow ND, Chang... Partial recovery of brain metabolism in methamphetamine abusers after ... Am J Psychiatry 2004
Falck RS, Carlson RG, Wan... Sources of information about MDMA (3,4-methylenedioxymethamphetamine):... Drug and Alcohol Dep... 2004
Thompson PM, Hayashi KM, ... Structural abnormalities in the brains of human subjects who use metha... J Neurosci 2004
Baumann MH, Clark RD, Bud... N-substituted piperazines abused by humans mimic the molecular mechani... Neuropsychopharmacol... 2005
Segura M, Farre M, Pichin... Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetami... Clin Pharmacokinet 2005
McCann UD, Szabo Z, Vrane... Positron emission tomographic studies of brain dopamine and serotonin ... Psychopharmacology (... 2008
Galloway GP, Singleton EG... How long does craving predict use of methamphetamine? Assessment of us... Subst Abuse 2009
Galloway GP, Singleton EG... An examination of drug craving over time in abstinent methamphetamine ... Am J Addict 2010
Hart CL, Marvin CB, Silve... Is Cognitive Functioning Impaired in Methamphetamine Users? A Critical... Neuropsychopharmacol... 2011
Angoa-Pérez M, Kane MJ, F... Mephedrone, an abused psychoactive component of 'bath salts' and metha... J Neurochem 2012